Clear cell carcinoma of the ovary: Is there a role of histology-specific treatment?

Table 2 Relapse rates of clear cell carcinoma patients who received FSS

stage	author	year	number of patients	relapse
Stage IA	Kajiyama [23]	2008	4	0% (0/4)
Stage IA	Satoh [24]	2010	15	0% (0/15)
	total		19	0% (0/19)
Stage IC	Schilder [22]	2001	5	0% (0/5)
	Kajiyama [23]	2008	6	17% (1/6)
	Satoh [24]	2010	15	33% (5/15)
	total		26	23% (6/26)